Bio-Rad Laboratories Inc
Company Profile
Business description
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
Contact
1000 Alfred Nobel Drive
HerculesCA94547
USAT: +1 510 724-7000
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2026
Employees
7,700
Stocks News & Analysis
stocks
Wide moat miner looking to shift focus
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,238.70 | 21.50 | 0.23% |
| CAC 40 | 8,361.46 | 44.96 | 0.54% |
| DAX 40 | 24,998.40 | 197.49 | 0.80% |
| Dow JONES (US) | 49,529.43 | 28.50 | 0.06% |
| FTSE 100 | 10,556.17 | 82.48 | 0.79% |
| HKSE | 26,705.94 | 138.82 | 0.52% |
| NASDAQ | 22,557.17 | 10.50 | 0.05% |
| Nikkei 225 | 57,283.06 | 716.57 | 1.27% |
| NZX 50 Index | 13,247.02 | 129.11 | 0.98% |
| S&P 500 | 6,839.81 | 3.64 | 0.05% |
| S&P/ASX 200 | 9,007.00 | 12.80 | 0.14% |
| SSE Composite Index | 4,082.07 | 51.95 | -1.26% |